CHANGES IN THE BASE COMPOSITION OF NUCLEAR RIBONUCLEIC ACID OF NEURONS DURING A SHORT PERIOD OF ENHANCED PROTEIN PRODUCTION

por Hydén, Holger, Egyházi, Endre
Publicado 1962

Adenosine selectively inhibits labeling of chromosomal RNA, especially hnRNA, probably by acting at or near the site of chain initiation

por Egyhazi, E, Holst, M
Publicado 1981

EXPERIMENTALLY INDUCED CHANGES IN THE BASE COMPOSITION OF THE RIBONUCLEIC ACIDS OF ISOLATED NERVE CELLS AND THEIR OLIGODENDROGLIAL CELLS

por Egyházi, Endre, Hydén, Holger
Publicado 1961

O6-methylguanine-DNA methyltransferase activities in biopsies of human melanoma tumours.

por Egyházi, S., Hansson, J., Ringborg, U.
Publicado 1995

EFFECTS OF α-AMANITIN ON IN VITRO LABELING OF RNA FROM DEFINED NUCLEAR COMPONENTS IN SALIVARY GLAND CELLS FROM CHIRONOMUS TENTANS

por Egyházi, E., D'Monte, B., Edström, J.-E.
Publicado 1972

IN SITU DEMONSTRATION OF DNA HYBRIDIZING WITH CHROMOSOMAL AND NUCLEAR SAP RNA IN CHIRONOMUS TENTANS

por Lambert, B., Wieslander, L., Daneholt, B., Egyházi, E., Ringborg, U.
Publicado 1972

INTRACELLULAR DISTRIBUTION OF LOW MOLECULAR WEIGHT RNA IN CHIRONOMUS TENTANS

por Egyházi, E., Daneholt, B., Edström, J.-E., Lambert, B., Ringborg, U.
Publicado 1971

O(6)-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma

por Ma, S, Egyházi, S, Ueno, T, Lindholm, C, Kreklau, E L, Stierner, U, Ringborg, U, Hansson, J
Publicado 2003

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

por Falkenius, Johan, Johansson, Hemming, Tuominen, Rainer, Frostvik Stolt, Marianne, Hansson, Johan, Egyhazi Brage, Suzanne
Publicado 2017

ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report

por Sakil, Habib A. M., Stantic, Marina, Wolfsberger, Johanna, Brage, Suzanne Egyhazi, Hansson, Johan, Wilhelm, Margareta T.
Publicado 2017

Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma

por Costa Svedman, Fernanda, Das, Ishani, Tuominen, Rainer, Darai Ramqvist, Eva, Höiom, Veronica, Egyhazi Brage, Suzanne
Publicado 2022

Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance

por Azimi, A, Pernemalm, M, Frostvik Stolt, M, Hansson, J, Lehtiö, J, Egyházi Brage, S, Hertzman Johansson, C
Publicado 2014

Chronic Pain Following Physical and Emotional Trauma: The Station Nightclub Fire

por Egyhazi, Rachel, Fregni, Felipe, Bravo, Gabriela L., Trinh, Nhi-Ha T., Ryan, Colleen M., Schneider, Jeffrey C.
Publicado 2014

Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma

por Svedman, Fernanda Costa, Lohcharoenkal, Warangkana, Bottai, Matteo, Brage, Suzanne Egyhazi, Sonkoly, Enikö, Hansson, Johan, Pivarcsi, Andor, Eriksson, Hanna
Publicado 2018

Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer

por Hjerpe, Elisabet, Egyhazi Brage, Suzanne, Carlson, Joseph, Frostvik Stolt, Marianne, Schedvins, Kjell, Johansson, Hemming, Shoshan, Maria, Åvall-Lundqvist, Elisabeth
Publicado 2013

Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status

por Das, Ishani, Wilhelm, Margareta, Höiom, Veronica, Franco Marquez, Rodolfo, Costa Svedman, Fernanda, Hansson, Johan, Tuominen, Rainer, Egyhàzi Brage, Suzanne
Publicado 2019

Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma

por Das, Ishani, Chen, Huiqin, Maddalo, Gianluca, Tuominen, Rainer, Rebecca, Vito W., Herlyn, Meenhard, Hansson, Johan, Davies, Michael A., Egyházi Brage, Suzanne
Publicado 2020

AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma

por Das, Ishani, Gad, Helge, Bräutigam, Lars, Pudelko, Linda, Tuominen, Rainer, Höiom, Veronica, Almlöf, Ingrid, Rajagopal, Varshni, Hansson, Johan, Helleday, Thomas, Egyházi Brage, Suzanne, Warpman Berglund, Ulrika
Publicado 2020

Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib

por Vidarsdottir, Linda, Fernandes, Rita Valador, Zachariadis, Vasilios, Das, Ishani, Edsbäcker, Elin, Sigvaldadottir, Ingibjorg, Azimi, Alireza, Höiom, Veronica, Hansson, Johan, Grandér, Dan, Egyházi Brage, Suzanne, Pokrovskaja Tamm, Katja
Publicado 2020

Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors

por Costa Svedman, Fernanda, Jalsenius, Marie, Höiom, Veronica, Grozman, Vitali, Bergqvist, Mattias, Söderdahl, Fabian, Eriksson, Hanna, Rotstein, Samuel, Ny, Lars, Ascierto, Paolo A., Brage, Suzanne Egyhazi, Helgadottir, Hildur
Publicado 2022